Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.6M
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
73.1M
-
Shares change
-
-1.04M
-
Total reported value, excl. options
-
$3.95B
-
Value change
-
-$58.8M
-
Put/Call ratio
-
0.34
-
Number of buys
-
142
-
Number of sells
-
-115
-
Price
-
$54.03
Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q2 2022
305 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q2 2022.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.1M shares
of 77.6M outstanding shares and own 94.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.74M shares), BlackRock Inc. (6.7M shares), WELLINGTON MANAGEMENT GROUP LLP (6.68M shares), Champlain Investment Partners, LLC (5.45M shares), EATON VANCE MANAGEMENT (4.23M shares), Capital Research Global Investors (3.87M shares), JANUS HENDERSON GROUP PLC (3.28M shares), Clearbridge Investments, LLC (2.55M shares), COOKE & BIELER LP (2.49M shares), and ALLIANCEBERNSTEIN L.P. (2.38M shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.